International Registration of Isolated STIC: to Report and Investigate the Risk of Serous Peritoneal Carcinomatosis

Launched by RADBOUD UNIVERSITY MEDICAL CENTER · Apr 26, 2024

Keywords

ClinConnect Summary

This clinical trial is focused on understanding a specific type of cancer called serous tubal intraepithelial carcinoma (STIC) and its potential to lead to a more serious condition known as peritoneal carcinomatosis, where cancer spreads to the lining of the abdomen. Researchers want to learn how often this spread happens in women who have been diagnosed with STIC and to identify certain characteristics of STIC that might increase the risk of this spread. This study is important because it aims to improve our understanding of how to better monitor and treat women at risk for these conditions.

To participate in this trial, women must have undergone a surgery called bilateral salpingectomy (removal of both fallopian tubes) and have a confirmed diagnosis of STIC from a tissue examination. Unfortunately, women who have already been diagnosed with invasive cancer at the time of their surgery cannot join the trial. While the study is not yet recruiting participants, those who qualify can expect to contribute valuable information to help doctors understand these conditions better, which could ultimately lead to improved care for future patients.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Women
• • Bilateral salpingectomy (with or without oophorectomy)
• • A serous tubal intraepithelial carcinoma at histopathological review
• Exclusion Criteria:
• • Invasive cancer at initial surgery or pathological examination (either macroscopic and/or microscopic)